# Scott Liu

> Scott Shi-Kau Liu is the founder, chairman and CEO of HanchorBio and a co-founder and former CEO of Shanghai Henlius Biotech. Trained at Soochow, Purdue and Stanford, he held quality and research leadership positions at United Biomedical, Bristol-Myers Squibb and Amgen before building businesses across Taiwan, China and the United States.

- **Role:** Founder, Chairman & CEO at HanchorBio Inc.
- **Organizations:** HanchorBio Inc., Shanghai Henlius Biotech, Fosun International, United Biomedical, Bristol-Myers Squibb, Amgen, National Sun Yat-sen University
- **Nationality:** American (listed in Henlius’ 2019 IPO prospectus)
- **Education:** Bachelor’s degree in microbiology, Soochow University, Taiwan, Ph.D. in biology, Purdue University, Postdoctoral training in biology, Stanford University, Business administration coursework (iMBA courses; no completed degree verified), Syracuse University
- **Known for:** Bristol-Myers Squibb Technical Operations Presidential Award, 2006., People of the Year in Bio-Industry recognition from the 17Talk Bio-Industry Awards, 2017., Co-founded Henlius and led it through its 2019 Hong Kong public listing.

## Career timeline

- **1993-1994** — University teaching appointment in biology at National Sun Yat-sen University.
- **1998-2003** — Director of quality operations and regulatory affairs at United Biomedical; also VP of R&D for Asia from October 1998 to March 2000.
- **2003-2007** — Associate director of biologics quality control at Bristol-Myers Squibb in Syracuse.
- **2007-2008** — Director of quality analytical laboratories at Amgen in Fremont.
- **2010** — Co-founded Shanghai Henlius Biotech with Wei-Dong Jiang; served as president and CEO.
- **2019** — Henlius listed on the Hong Kong Stock Exchange on September 25.
- **2020** — Founded HanchorBio.
- **2022** — Received the CABS K. Fong Award in Life Sciences.
- **2026** — Led HanchorBio as it completed IPO bookbuilding for a Taiwan Innovation Board listing scheduled for May 29.

## Achievements

- Bristol-Myers Squibb Technical Operations Presidential Award, 2006.
- People of the Year in Bio-Industry recognition from the 17Talk Bio-Industry Awards, 2017.
- Co-founded Henlius and led it through its 2019 Hong Kong public listing.
- CABS K. Fong Award in Life Sciences, 2022.
- Named to The Silicon Review’s 30 Best CEOs of the Year 2024.

## Latest updates

- **2026-10** — HanchorBio announced BioJapan participation in Yokohama with more than 15 partnering meetings scheduled; its October 12 announcement identifies Liu as chairman and CEO.
- **2026-09** — HanchorBio held its second R&D Day and described its global growth and external partnership strategy.
- **2026-07** — Liu attended the signing of an MOU between HanchorBio subsidiary FBD Biologics and InxMed, alongside InxMed founder Zaiqi Wang.
- **2026-05** — HanchorBio completed IPO bookbuilding at NT$120 per share and introduced OrbiMed as a strategic investor.
- **2026-04** — HanchorBio selected Bloomberg for strategic decision support, including portfolio planning and competitive monitoring.

## Links

- Website: https://www.hanchorbio.com/
- LinkedIn: https://www.linkedin.com/in/scott-liu-066a1611

---

Profile page: https://yespress.io/scott-liu
Published by YesPress — https://yespress.io
Last updated: 2026-10-14